PROCEPT BioRobotics (PRCT) Net Income towards Common Stockholders (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$31.6 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 27.9% year-over-year to -$31.6 million in Q1 2026; TTM through Mar 2026 was -$185.9 million, a 65.81% decrease from a year earlier, with the FY2025 full-year figure at -$95.6 million, down 4.55% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$31.6 million, up from -$32.6 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for PRCT reached as high as -$19.3 million in Q2 2022 and fell as low as -$78.0 million in Q1 2023.
• Historically, Net Income towards Common Stockholders has averaged -$36.7 million across 5 years, with a median of -$31.6 million in 2026.
• Across the five-year window, Net Income towards Common Stockholders slumped 296.97% in 2023 and jumped 46.71% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$24.0 million in 2022, then slipped by 27.99% to -$30.7 million in 2023, then surged by 32.64% to -$20.7 million in 2024, then tumbled by 57.96% to -$32.6 million in 2025, then climbed by 3.09% to -$31.6 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$31.6 million in Q1 2026, -$32.6 million in Q4 2025, and -$60.7 million in Q3 2025.